FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and represents a fluorescent cell line C6-TagRFP-TurboFP635, which expresses red fluorescent proteins and is used to study brain glioma in vitro and in vivo, and comprises vectors pTagRFP-C and pTurboFP635-C. Invention also relates to a method for preparing said cell line.
EFFECT: invention enables higher tumour cell survival during transfection and provides high survival rate of cells in the brain of animals after their implantation with broader technological capabilities of studying the dynamics of brain tumour.
5 cl, 3 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUMORAL AGENT ON BASIS OF IMMUNOPOLISOME BIOLOGICAL STRUCTURE, WAY OF ITS OBTAINING AND VECTORIAL DELIVERY IN CENTRAL NERVOUS SYSTEM AT TUMORAL PROCESS | 2007 |
|
RU2336901C1 |
| BINARY IMMUNOLIPOSOMAL NANOSYSTEM OF TARGETED DELIVERY TO CONNEXIN -43 POSITIVE TUMOUR CELLS | 2009 |
|
RU2422154C2 |
| STEM CELL PREPARATION WITH REPROGRAMMED CELL SIGNALLING, METHOD FOR MAKING THIS PREPARATION AND APPLICATION THEREOF | 2008 |
|
RU2428475C2 |
| MEAN FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS TO CELLS OF MAMMALS | 2014 |
|
RU2572575C1 |
| TUMOUR VACCINE CONTAINING ALLOGENIC OR XENOGENIC TUMOUR CELLS | 2007 |
|
RU2456997C2 |
| STABLE HUMAN BREAST CANCER CARCINOMA CELL LINE SKBR-KAT | 2018 |
|
RU2709675C1 |
| FLUORESCENT CELL LINE mel Kor-TurboRFP AND METHOD FOR USING IT FOR IN VITRO STUDIES IN EXPERIMENTAL ONCOLOGY | 2009 |
|
RU2458123C2 |
| METHODS OF OBTAINMENT AND APPLICATION OF MULTIPOTENT CELL POPULATIONS | 2008 |
|
RU2535365C2 |
| LIPOSOME DELIVERY OF COMPOSITIONS BASED ON VITAMIN E | 2002 |
|
RU2328273C2 |
| REPORTER MONOCLONAL CELL LINE HEK-293/5-HT4R, EXPRESSING MURINE RECOMBINANT SEROTONIN RECEPTOR TYPE 5HT4 | 2022 |
|
RU2817234C2 |
